Ming‐Tsang Chiao

664 total citations
19 papers, 518 citations indexed

About

Ming‐Tsang Chiao is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ming‐Tsang Chiao has authored 19 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Ming‐Tsang Chiao's work include Glioma Diagnosis and Treatment (5 papers), Herbal Medicine Research Studies (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ming‐Tsang Chiao is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Herbal Medicine Research Studies (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ming‐Tsang Chiao collaborates with scholars based in Taiwan, China and United States. Ming‐Tsang Chiao's co-authors include Chiung‐Chyi Shen, Yi‐Chin Yang, Wen-Yu Cheng, Jiunn‐Liang Ko, Ning‐Sun Yang, Bai‐Shuan Liu, Lie‐Fen Shyur, Chiou‐Ying Yang, Kuo‐Chen Yeh and Chia-Chung Hou and has published in prestigious journals such as Autophagy, BMC Genomics and Genomics.

In The Last Decade

Ming‐Tsang Chiao

19 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Tsang Chiao Taiwan 12 243 110 84 78 72 19 518
Shee‐Ping Chen Taiwan 12 242 1.0× 61 0.6× 74 0.9× 67 0.9× 65 0.9× 16 577
Peiyuan Zhao China 7 245 1.0× 30 0.3× 97 1.2× 101 1.3× 37 0.5× 15 425
Giselle Pinto de Faria Lopes Brazil 9 392 1.6× 64 0.6× 82 1.0× 20 0.3× 108 1.5× 19 588
Carolina Nör Brazil 15 399 1.6× 105 1.0× 119 1.4× 22 0.3× 209 2.9× 27 881
Ángelo Torres Chile 14 315 1.3× 149 1.4× 153 1.8× 15 0.2× 99 1.4× 21 609
Sejin Jeon South Korea 15 416 1.7× 17 0.2× 80 1.0× 59 0.8× 57 0.8× 24 728
Ya-Wei Guo China 12 303 1.2× 21 0.2× 138 1.6× 31 0.4× 74 1.0× 19 622
Jingping Fan China 14 276 1.1× 21 0.2× 65 0.8× 13 0.2× 40 0.6× 27 505
William M.W. Cheung Hong Kong 17 382 1.6× 19 0.2× 29 0.3× 23 0.3× 46 0.6× 20 535

Countries citing papers authored by Ming‐Tsang Chiao

Since Specialization
Citations

This map shows the geographic impact of Ming‐Tsang Chiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Tsang Chiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Tsang Chiao more than expected).

Fields of papers citing papers by Ming‐Tsang Chiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Tsang Chiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Tsang Chiao. The network helps show where Ming‐Tsang Chiao may publish in the future.

Co-authorship network of co-authors of Ming‐Tsang Chiao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Tsang Chiao. A scholar is included among the top collaborators of Ming‐Tsang Chiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Tsang Chiao. Ming‐Tsang Chiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cheng, Wen-Yu, Chiung‐Chyi Shen, Ming‐Tsang Chiao, et al.. (2024). Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression. Current Neurovascular Research. 21(3). 320–336. 2 indexed citations
2.
Chiao, Ming‐Tsang, Tzu‐Hung Hsiao, Chih‐Hsiang Liao, et al.. (2024). Genetic mutation patterns among glioblastoma patients in the Taiwanese population – insights from a single institution retrospective study. Cancer Gene Therapy. 31(6). 894–903. 15 indexed citations
3.
Cheng, Wen-Yu, Chiung‐Chyi Shen, Ming‐Tsang Chiao, et al.. (2023). Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme. BMC Cancer. 23(1). 886–886. 1 indexed citations
4.
Shen, Chiung‐Chyi, Wen-Yu Cheng, Ming‐Tsang Chiao, et al.. (2020). Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC Cancer. 20(1). 709–709. 9 indexed citations
5.
Cheng, Wen-Yu, Kuan‐Chih Chow, Ming‐Tsang Chiao, Yi‐Chin Yang, & Chiung‐Chyi Shen. (2020). Higher Levels of Dynamin-related Protein 1 are Associated with Reduced Radiation Sensitivity of Glioblastoma Cells. Current Neurovascular Research. 17(4). 446–463. 6 indexed citations
7.
Shen, Chiung‐Chyi, et al.. (2016). Two Novel Heparin-binding Vascular Endothelial Growth Factor Splices, L-VEGF144 and L-VEGF138, are Expressed in Human Glioblastoma Cells. Current Neurovascular Research. 13(3). 207–218. 5 indexed citations
8.
Yang, Meng‐Yin, Ming‐Tsang Chiao, Hsu‐Tung Lee, et al.. (2014). An innovative three‐dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior. Journal of Biomedical Materials Research Part B Applied Biomaterials. 103(3). 618–628. 9 indexed citations
9.
Cheng, Wen-Yu, et al.. (2013). Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity. Molecular Biology Reports. 40(9). 5315–5326. 58 indexed citations
10.
Chiao, Ming‐Tsang, Wen-Yu Cheng, Yi‐Chin Yang, Chiung‐Chyi Shen, & Jiunn‐Liang Ko. (2013). Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy. 9(10). 1509–1526. 111 indexed citations
11.
Shen, Chiung‐Chyi, et al.. (2013). Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 18 indexed citations
12.
Chiao, Ming‐Tsang, Yi‐Chin Yang, Wen-Yu Cheng, Chiung‐Chyi Shen, & Jiunn‐Liang Ko. (2011). CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in Vivo. Current Neurovascular Research. 8(3). 210–219. 48 indexed citations
13.
Yang, Yi‐Chin, et al.. (2011). Transplantation of Adipose Tissue-Derived Stem Cells for Treatment of Focal Cerebral Ischemia. Current Neurovascular Research. 8(1). 1–13. 37 indexed citations
14.
Shen, Chiung‐Chyi, Yi‐Chin Yang, Ming‐Tsang Chiao, et al.. (2010). Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke. Current Neurovascular Research. 7(1). 6–14. 31 indexed citations
15.
Shen, Chiung‐Chyi, et al.. (2010). Intravenous Implanted Neural Stem Cells Migrate to Injury Site, Reduce Infarct Volume, and Improve Behavior after Cerebral Ischemia. Current Neurovascular Research. 7(3). 167–179. 35 indexed citations
16.
Staniforth, Vanisree, Ming‐Tsang Chiao, Chia-Chung Hou, et al.. (2008). Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells. BMC Genomics. 9(1). 479–479. 37 indexed citations
17.
Su, Pei‐Fen, Vanisree Staniforth, Ming‐Tsang Chiao, et al.. (2008). Immunomodulatory effects of phytocompounds characterized by in vivo transgenic human GM-CSF promoter activity in skin tissues. Journal of Biomedical Science. 15(6). 813–822. 23 indexed citations
18.
Liang, Chi‐Ming, Ivan‐Chen Cheng, Yung‐Chih Cheng, et al.. (2006). DNA vaccination against foot‐and‐mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. The Journal of Gene Medicine. 8(9). 1182–1191. 17 indexed citations
19.
Chiao, Ming‐Tsang, Chia-Chung Hou, Shih‐Chang Chien, et al.. (2006). Modulatory effects of Echinacea purpurea extracts on human dendritic cells: A cell- and gene-based study. Genomics. 88(6). 801–808. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026